CDH2 and central nervous system cancer: In this study, we used shRNA to inhibit the expression levels of Notch1 in glioma cells, and we revealed that EMT (N-cadherin decreased, E-cadherin increased) and the proliferation, migration, and invasion of cancer cells were significantly decreased.